LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | BX-912 | 3.33 | uM | LJP5 | 2 | L20 | 72 | hr | 1311 | 1814 | 5100 | 0.3557 | 0.1800 |
MDA-MB-231 | BX-912 | 3.33 | uM | LJP5 | 3 | L20 | 72 | hr | 1311 | 2119 | 5010 | 0.4229 | 0.2815 |
MDA-MB-231 | BX-912 | 10 | uM | LJP5 | 1 | L19 | 72 | hr | 1311 | 1289 | 5128 | 0.2514 | -0.0088 |
MDA-MB-231 | BX-912 | 10 | uM | LJP5 | 2 | L19 | 72 | hr | 1311 | 1148 | 5100 | 0.2251 | -0.0658 |
MDA-MB-231 | BX-912 | 10 | uM | LJP5 | 3 | L19 | 72 | hr | 1311 | 1185 | 5010 | 0.2365 | -0.0512 |
MDA-MB-231 | Selumetinib | 0.04 | uM | LJP6 | 1 | M12 | 72 | hr | 1311 | 3887 | 4870 | 0.7981 | 0.7753 |
MDA-MB-231 | Selumetinib | 0.04 | uM | LJP6 | 2 | M12 | 72 | hr | 1311 | 3717 | 4961 | 0.7492 | 0.7206 |
MDA-MB-231 | Selumetinib | 0.04 | uM | LJP6 | 3 | M12 | 72 | hr | 1311 | 3983 | 4973 | 0.8008 | 0.7818 |
MDA-MB-231 | Selumetinib | 0.12 | uM | LJP6 | 1 | M11 | 72 | hr | 1311 | 3456 | 4870 | 0.7096 | 0.6685 |
MDA-MB-231 | Selumetinib | 0.12 | uM | LJP6 | 2 | M11 | 72 | hr | 1311 | 3256 | 4961 | 0.6562 | 0.6059 |
MDA-MB-231 | Selumetinib | 0.12 | uM | LJP6 | 3 | M11 | 72 | hr | 1311 | 3086 | 4973 | 0.6205 | 0.5604 |
MDA-MB-231 | Selumetinib | 0.37 | uM | LJP6 | 1 | M10 | 72 | hr | 1311 | 2747 | 4870 | 0.5640 | 0.4778 |
MDA-MB-231 | Selumetinib | 0.37 | uM | LJP6 | 2 | M10 | 72 | hr | 1311 | 2887 | 4961 | 0.5819 | 0.5083 |
MDA-MB-231 | Selumetinib | 0.37 | uM | LJP6 | 3 | M10 | 72 | hr | 1311 | 2828 | 4973 | 0.5686 | 0.4911 |
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 1 | M09 | 72 | hr | 1311 | 2484 | 4870 | 0.5100 | 0.4013 |
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 2 | M09 | 72 | hr | 1311 | 2419 | 4961 | 0.4875 | 0.3756 |
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 3 | M09 | 72 | hr | 1311 | 2628 | 4973 | 0.5284 | 0.4353 |
MDA-MB-231 | Selumetinib | 3.33 | uM | LJP6 | 1 | M08 | 72 | hr | 1311 | 2059 | 4870 | 0.4228 | 0.2690 |
MDA-MB-231 | Selumetinib | 3.33 | uM | LJP6 | 2 | M08 | 72 | hr | 1311 | 2079 | 4961 | 0.4190 | 0.2712 |
MDA-MB-231 | Selumetinib | 3.33 | uM | LJP6 | 3 | M08 | 72 | hr | 1311 | 2211 | 4973 | 0.4445 | 0.3120 |
MDA-MB-231 | Selumetinib | 10 | uM | LJP6 | 1 | M07 | 72 | hr | 1311 | 1791 | 4870 | 0.3678 | 0.1789 |
MDA-MB-231 | Selumetinib | 10 | uM | LJP6 | 2 | M07 | 72 | hr | 1311 | 1694 | 4961 | 0.3414 | 0.1425 |
MDA-MB-231 | Selumetinib | 10 | uM | LJP6 | 3 | M07 | 72 | hr | 1311 | 1771 | 4973 | 0.3561 | 0.1690 |
MDA-MB-231 | MK2206 | 0.04 | uM | LJP6 | 1 | F06 | 72 | hr | 1311 | 4979 | 4870 | 1.0223 | 1.0235 |
MDA-MB-231 | MK2206 | 0.04 | uM | LJP6 | 2 | F06 | 72 | hr | 1311 | 5017 | 4961 | 1.0112 | 1.0116 |